In vivo, BTK inhibited spontaneous germinal center formation in lupus mice, and decreased splenic B cell numbers (marginal zone, follicular, B1, plasmablasts, and plasma cells), and circulating B cells, antibodies and/or autoantibodies [23–25, 31]. The gene discussed is BTK; the disease is systemic lupus erythematosus.